Dr. Craig A. Thompson is a world leader in interventional cardiology and in the field of complex cardiovascular interventions, including therapies for chronic total occlusive vascular diseases. He has performed thousands of cardiac and vascular interventions, and chronic total occlusion percutaneous coronary intervention's (CTO PCI's) in the cardiac and peripheral vessels. In partnership with many colleagues throughout the United States and globally, Dr. Thompson has assembled the first and largest experience in the United States for retrograde techniques and other innovative techniques and technologies for chronic total occlusion. The Yale CTO PCI program is among the most active and innovative in the world for management of occlusive coronary diseases. Dr. Thompson has actively participated or led many efforts for innovative technique refinement and technology development for CTO PCI.
Dr. Craig A. Thompson previously served as Director of Cardiovascular Catheterization and Intervention with Yale New Haven Hospital and Director of Invasive Cardiology and Vascular Medicine with Yale University School of Medicine in New Haven, CT. He is now senior vice president and chief medical officer, Interventional Cardiology, at Boston Scientific responsible for driving the development of innovative medical solutions within the Boston Scientific Interventional Cardiology business.
